Source-to-Output Integration of Archived Evidence from an Immunoregulatory-Conditioned Human PBMC Extracellular Preparation
Ramón Gutiérrez-Sandoval, Francisco Gutiérrez-Castro, Natalia Muñoz-Godoy, Ider Rivadeneira, Andy Lagos, Jordan Iturra, Francisco Krakowiak, Ignacio Muñoz, Cristián Peña-Vargas, Andrés ToledoBackground: Sequential cytokine conditioning of human peripheral blood mononuclear cell (PBMC)-derived cultures can generate complex extracellular outputs, but retrospective development archives frequently preserve heterogeneous analytical records at different levels of resolution. Methods: This retrospective descriptive study integrated the complete set of interpretable summary-level records available within one documented IL-4/GM-CSF-supported differentiation and subsequent IL-10/TGF-β1 conditioning workflow. This study was designed to evaluate provenance, analytical coherence, and evidence boundaries; unavailable raw, replicate-level, or implementation-level information was not reconstructed. Results: A single represented archived Annexin V/7-AAD output comprised 26,071 events with 99.66% viability. The recovered preparation was represented by an archived heterogeneous particle-associated signal with a predominant region at approximately 170–240 nm and an archived immunoblot record reporting CD9, CD63, CD81, and TSG101 detection. An independent aggregate record labeled as representing ten conditioned cultures reported mean final-environment values of 25,320.16 pg/mL IL-10, 659.35 pg/mL IL-4, 99.61 pg/mL IL-6, and 3.01 pg/mL TNF-α. Because IL-10 and IL-4 were conditioning inputs, these values were not interpreted as de novo cytokine secretion. Conclusions: This study establishes a provenance-controlled method for integrating heterogeneous archived evidence without conflating experimental units, assigning unsupported vesicle biogenesis, or converting compositional observations into functional claims. The resulting analytical baseline defines dedicated next-stage questions for fraction-resolved composition and prospective functional validation.